Showing results (621-630 of 689) with videos related to

Sort By:
Pageof 69
Nature Communications|April 30, 2025
Structure Sensitivity and Catalyst Restructuring for CO2 Electro-reduction on CopperDongfang Cheng, Khanh-Ly C Nguyen, Vaidish Sumaria, et al.
Plos Pathogens|October 23, 2018
CD11c-expressing Ly6C+CCR2+ monocytes constitute a reservoir for efficient Leishmania proliferation and cell-to-cell transmissionSandrina Heyde, Lars Philipsen, Pauline Formaglio, et al.
Antibiotics (Basel, Switzerland)|April 27, 2026
Evaluation of Intravenous Administration of Anti-Infective Agents and Documentation Quality in Orthopedics and Trauma Surgery: A Quantitative Study on Discrepancies Between Physician Prescriptions and Nursing RecordsAnna-Judith Dahse, Laura Klimpel, Katrin Heinitz, et al.
The ISME Journal|November 17, 2025
Differential microbial community assembly following co-housing versus microbiota transplantJames S Weagley, Luis Alberto Chica Cárdenas, Ana Romani, et al.
Biorxiv : the Preprint Server for Biology|June 9, 2023
Microbiota produced indole metabolites disrupt host cell mitochondrial energy production and inhibitLisa J Funkhouser-Jones, Rui Xu, Georgia Wilke, et al.
Cell Reports|June 29, 2023
Microbiota-produced indole metabolites disrupt mitochondrial function and inhibit Cryptosporidium parvum growthLisa J Funkhouser-Jones, Rui Xu, Georgia Wilke, et al.
Cancers|July 15, 2026
Real-World Data on the Use of Nivolumab Monotherapy in the Treatment of Advanced Renal Cell Carcinoma After Prior Therapy: Final Results from the Non-Interventional NORA StudyMarc-Oliver Grimm, Viktor Grünwald, Harald Müller-Huesmann, et al.
Obesity Surgery|November 19, 2014
Roux-en-Y gastric bypass decreases pro-inflammatory and thrombotic biomarkers in individuals with extreme obesityBárbara Dal Molin Netto, Solange Cravo Bettini, Ana Paula Grotti Clemente, et al.
The American Journal of Medicine|August 2, 2003
C-reactive protein and coronary events following percutaneous coronary angioplastyRobbert J de Winter, Karel T Koch, Jan P van Straalen, et al.
Annals of Hematology|October 4, 2023
Real-world analysis of ruxolitinib in myelofibrosis: interim results focusing on patients who were naïve to JAK inhibitor therapy treated within the JAKoMo non-interventional, phase IV trialSteffen Koschmieder, Susanne Isfort, Clemens Schulte, et al.
Pageof 69